how many people use glp-1 drugs Agonists Weight Loss Market Report, 2025-2030 Products - Data Briefs -

[DOI] [PubMed] [Google Scholar] 59.Giuliano F

The mechanism is plausible: dopamine D2 receptor modulation and serotonergic interactions can shift the neurotransmitter balance toward wakefulness

It has been recognized for its detox functions as well as its ability to fight oxidative stress

Its core mechanism is stimulation of the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH)

More serious risks include acute pancreatitis, gallbladder disease, and elevated resting heart rate

Loss of NF1 gene function, mutations in TP53 or CDKN2A/B, and expression of SOX10, H3K27me3 loss, or PRC2 complex mutations may support the diagnosis of MPNST (Reuss et al., 2020)